background
recent
previou
studi
shown
guinea
pig
infect
transmit
human
influenza
virus
therefor
guinea
pig
may
use
anim
model
better
understand
influenza
infect
assess
vaccin
strategi
fulli
character
model
antibodi
respons
follow
either
infectionreinfect
human
influenza
immun
homolog
recombin
hemagglutinin
ha
protein
studi
result
serolog
sampl
collect
test
antiha
immunoglobulin
elisa
antivir
antibodi
hemagglutin
inhibit
hi
recognit
linear
epitop
peptid
scan
pepscan
anim
inocul
infecti
viru
demonstr
pronounc
viral
replic
subsequ
serolog
convers
anim
either
immun
homolog
ha
antigen
infect
show
rel
rapid
rise
antibodi
titer
ha
glycoprotein
elisa
assay
antivir
antibodi
measur
hi
assay
detect
second
inocul
pepscan
data
identifi
previous
recogn
newli
defin
linear
epitop
conclus
infect
andor
recombin
ha
immun
guinea
pig
wyom
influenza
viru
result
rel
rapid
product
viralspecif
antibodi
thu
demonstr
strong
immunogen
major
viral
structur
protein
anim
model
influenza
infect
sensit
immun
respons
support
util
guinea
pig
use
anim
model
influenza
infect
immun
common
mammalian
model
use
influenza
viru
research
mous
suscept
infect
mani
unadapt
human
influenza
virus
serotyp
shed
viru
respiratori
tract
ferret
macaqu
increas
tropism
mani
primari
influenza
isol
expens
maintain
difficult
hous
base
larg
recapitul
human
diseas
sign
ferret
also
use
deriv
serotyp
reagent
assess
antigen
distanc
isol
potenti
vaccin
strain
howev
recent
report
suggest
ferret
may
faith
mimic
human
immun
respons
serolog
test
use
ferret
sera
may
accur
assess
vaccin
strain
efficaci
therefor
need
develop
addit
permiss
small
anim
model
influenza
viru
infect
exhibit
viru
shed
serial
sampl
collect
anim
model
allow
investig
determin
titer
durat
viru
shed
individu
anim
multipl
time
without
euthanasia
character
anim
model
capabl
replic
transmit
unadapt
human
avian
andor
swine
influenza
virus
valuabl
studi
test
new
improv
vaccin
immunobiot
antivir
two
promis
altern
anim
model
guinea
pig
cotton
rat
recent
investig
analysi
human
influenza
viru
influenza
vaccin
studi
focu
guinea
pig
model
influenza
guinea
pig
mani
attract
featur
use
anim
model
influenza
immun
infect
guinea
pig
rel
inexpens
easi
maintain
larger
studi
compar
ferret
simian
readili
infect
primari
isol
human
influenza
strain
potenti
use
viru
evolutionari
prophylact
therapeut
studi
small
number
report
describ
experiment
infect
guinea
pig
human
influenza
virus
publish
recent
other
advanc
guinea
pig
model
studi
viru
infect
spread
vaccinechalleng
model
guinea
pig
readili
infect
human
influenza
isol
without
prior
tissu
cultur
anim
adapt
infect
guinea
pig
appear
center
larg
upper
nasorespiratori
tract
anim
pass
viru
other
via
aerosol
transmiss
recent
studi
demonstr
acut
viral
replic
moder
virul
highli
pathogen
pandem
virus
addit
lowpathogen
avian
human
virus
guinea
pig
overal
purpos
current
studi
character
immunolog
respons
guinea
pig
infect
viru
immun
ha
protein
assess
valu
guinea
pig
model
futur
immunolog
assay
vaccinechalleng
studi
prophylact
properti
haderiv
vaccin
rel
eas
product
immun
respons
subunit
studi
guinea
pig
model
result
support
util
guinea
pig
use
anim
model
influenza
infect
immun
four
group
guinea
pig
chosen
neg
control
infect
posit
control
receiv
infect
group
immun
low
dose
recombin
ha
protein
anoth
high
dose
elisa
extinct
titer
group
control
group
serolog
studi
remain
neg
unchang
throughout
studi
two
guinea
pig
group
inocul
intranas
plaqueform
unit
awyom
viru
allow
recov
infect
week
reinocul
dose
viru
nasal
wash
sampl
collect
day
post
infect
dpi
guinea
pig
exhibit
outward
clinic
sign
infect
viru
recov
nasal
wash
anim
dpi
peak
titer
progeni
viru
studi
occur
day
rang
pfuml
nasal
wash
fluid
long
et
al
prepar
serolog
sampl
prepar
cours
regimen
analysi
total
antiha
antibodi
ha
elisa
antivir
antibodi
hi
assay
identif
linear
ha
epitop
pepscan
elisa
equal
volum
sera
individu
use
produc
pool
time
point
group
assess
level
total
haspecif
antibodi
serolog
sampl
assay
elisa
use
plate
coat
commerci
prepar
fulllength
wyom
ha
glycoprotein
figur
inocul
viru
subsequ
infect
guinea
pig
result
rise
elisa
titer
ha
protein
nd
week
continu
increas
week
guinea
pig
receiv
second
inocul
viru
week
peak
viru
titer
nasal
wash
sampl
occur
day
determin
pfuml
two
anim
antiha
elisa
titer
rose
second
infect
live
viru
antivir
activ
sera
measur
hi
assay
figur
contrast
elisa
result
group
hi
titer
detect
week
initi
infect
rose
reinfect
week
signific
increas
titer
preinfect
sera
detect
follow
three
week
peak
titer
decreas
slightli
figur
analysi
serum
pool
infect
guinea
pig
serum
pool
test
total
habind
antibodi
reactiv
fulllength
ha
protein
standard
elisa
solid
antivir
titer
use
hi
assay
dash
arrow
along
xaxi
indic
inocul
date
group
error
bar
elisa
extinct
titer
shown
readili
seen
due
small
size
two
immun
guinea
pig
group
group
demonstr
similar
pattern
increas
antibodi
titer
cours
four
recombin
ha
protein
inocul
two
dose
antigen
initi
use
determin
sensit
immun
reactiv
ha
antigen
prior
vaccinechalleng
studi
similar
subunit
antigen
group
lower
antigen
dose
elisa
titer
initi
lag
behind
group
higher
antigen
dose
caught
final
boost
equival
amount
ha
microgram
group
figur
interestingli
elisa
titer
persist
high
level
month
follow
final
immun
show
littl
sign
decay
signific
differ
found
elisa
titer
group
confid
level
p
anova
antivir
hi
titer
group
haimmun
anim
increas
second
third
fourth
inocul
figur
inflect
hi
titer
graph
roughli
parallel
antiha
elisa
titer
throughout
studi
final
boost
week
hi
titer
continu
rise
increas
neg
control
persist
week
follow
last
immun
drop
magnitud
sera
group
neg
control
remain
neg
throughout
studi
specif
immun
respons
ha
protein
assess
use
western
blot
analysi
figur
fulllength
recombin
ha
protein
electrophores
denatur
polyacrylamid
gel
transfer
nitrocellulos
membran
cut
strip
probe
guinea
pig
sera
lane
show
neg
reactiv
observ
use
sera
mockimmun
anim
lane
demonstr
serolog
recognit
ha
antigen
anim
infect
influenza
viru
immun
purifi
ha
protein
although
sampl
boil
sdsbuffer
contain
put
dimer
trimer
form
ha
protein
appar
slowermigr
speci
character
reactiv
linear
epitop
serum
pool
sequenti
bleed
infect
guinea
pig
group
test
bind
librari
overlap
wyom
ha
peptid
figur
prior
inocul
viru
sera
show
potenti
reactiv
peptid
panel
peptid
within
epitop
overlap
c
epitop
outsid
defin
epitop
although
unclear
preinfect
sera
recogn
peptid
reactiv
remain
throughout
studi
reactiv
wane
second
week
postinfect
reactiv
peptid
outsid
defin
epitop
increas
week
postinfect
also
observ
sera
figur
analysi
serum
pool
immun
guinea
pig
sera
pool
test
antibodi
bind
nondenatur
fulllength
ha
protein
elisa
denot
solid
line
sera
pool
also
test
antivir
activ
hi
shown
dash
line
neg
control
anim
group
discontinu
week
arrow
along
xaxi
indic
immun
boost
date
error
bar
extinct
titer
shown
due
small
size
visibl
western
blot
analysi
sera
immun
infect
guinea
pig
fulllength
recombin
ha
sera
protein
scienc
inc
electrophores
denatur
polyacrylamid
gel
transfer
membran
lane
cut
strip
probe
guinea
pig
sera
confirm
specif
reactiv
lane
group
mock
infect
sera
lane
group
influenza
infect
sera
lane
group
immun
lower
concentr
ha
protein
sera
lane
group
immun
higher
concentr
ha
protein
sera
week
panel
e
f
signal
strength
increas
sera
week
postinfect
panel
c
return
preimmun
level
week
panel
immun
reactiv
sera
haimmun
guinea
pig
compar
influenzainfect
guinea
pig
figur
sera
mockimmun
anim
group
panel
figur
react
peptid
previous
seen
sera
preinfect
guinea
pig
figur
mockimmun
guinea
pig
age
develop
measur
reactiv
peptid
overlap
e
epitop
immun
lower
dose
ha
antigen
sera
group
anim
initi
increas
overal
reactiv
repres
peptid
panel
enhanc
reactiv
peptid
panel
immedi
prior
second
boost
reactiv
mani
peptid
decreas
reactiv
primarili
seen
panel
persist
studi
addit
boost
weak
reactiv
peptid
c
epitop
strong
activ
peptid
outsid
defin
epitop
observ
panel
prior
inocul
sera
higher
dose
immun
group
group
show
similar
low
level
reactiv
seen
two
immun
group
panel
week
sera
group
anim
recogn
peptid
moder
level
reactiv
panel
reactiv
epitop
peptid
increas
week
peak
week
decreas
week
similar
seen
group
reactiv
peptid
observ
later
bleed
pepscan
data
serum
sampl
group
collect
week
demonstr
pattern
peptid
bind
similar
week
data
shown
tabl
contain
summari
highli
reactiv
peptid
recogn
guinea
pig
sera
posit
reactiv
peptid
locat
threedimension
structur
relat
strain
studi
figur
panel
ad
figur
show
ribbon
diagram
monomer
ectodomain
ha
residu
epitop
ae
color
figur
identifi
locat
peptid
seen
preinfect
mock
immun
sera
peptid
contain
amino
acid
residu
previous
map
epitop
peptid
locat
membraneproxim
posit
previous
undefin
area
antigen
interest
figur
show
locat
two
peptid
identifi
pepscan
influenza
infect
guinea
pig
peptid
figur
identifi
posit
peptid
also
contain
epitop
recogn
sera
immun
anim
seen
figur
peptid
locat
membraneproxim
stem
ha
glycoprotein
region
previous
note
contain
epitop
major
aim
research
group
develop
broadli
protect
vaccin
stimul
crossprotect
immun
multipl
strain
human
influenza
virus
process
develop
test
vaccin
stimul
broaden
immun
necessari
rais
sera
multipl
speci
anim
analysi
crossstrain
antivir
respons
addit
would
help
assess
protect
crossstrain
challeng
multipl
anim
model
attract
guinea
pig
model
infect
influenza
character
immun
respons
infect
immun
guinea
pig
present
immunolog
figur
pepscan
elisa
serum
pool
guinea
pig
infect
influenza
viru
serum
pool
group
anim
analyz
recognit
linear
epitop
reactiv
overlap
peptid
bound
microtit
plate
sequenti
bleed
test
preble
b
c
e
f
week
initi
infect
reactiv
peptid
sera
infect
compar
result
preinfect
sera
identifi
virusspecif
epitop
induc
infect
comparison
guinea
pig
infect
intranas
viru
immun
homolog
ha
glycoprotein
attract
potenti
subunit
vaccin
candid
contrast
serolog
result
infect
immun
anim
provid
interest
insight
data
demonstr
guinea
pig
readili
seroconvert
respons
intranas
inocul
viru
immun
recombin
ha
glycoprotein
rise
bind
antibodi
elisa
posit
preced
develop
antivir
antibodi
determin
hemagglutinininhibit
hi
posit
infect
immun
group
guinea
pig
initi
lag
period
follow
strong
correl
continu
elev
bind
antivir
hi
antibodi
elisa
titer
rose
approxim
titer
singl
inocul
either
infecti
viru
purifi
ha
antigen
peak
elisa
titer
infect
anim
reach
immun
anim
reach
howev
group
limit
two
dose
titer
may
close
match
group
measur
antivir
titer
requir
second
dose
viru
immunogen
hi
titer
infect
immun
anim
reach
approxim
decay
slightli
time
lack
measur
antivir
immun
respons
observ
second
inocul
experiment
group
may
due
lower
sensit
hi
assay
necessarili
indic
first
infect
immun
elicit
hi
respons
elisa
antivir
antibodi
titer
persist
mani
week
follow
final
infecti
innocula
boost
ha
protein
littl
decay
elisa
hi
titer
observ
week
follow
final
ha
immun
week
better
understand
epitop
recogn
antiha
antibodi
respons
experiment
anim
model
epitop
compar
human
immun
respons
could
facilit
rapid
advanc
vaccin
design
five
domin
epitop
ae
ha
glycoprotein
previous
character
immunolog
reactiv
human
anim
evolutionari
variabl
natur
infect
human
pepscan
analysi
conduct
map
linear
b
cell
epitop
intend
peptid
color
cyan
structur
drawn
use
pymol
correl
immunolog
reactiv
previou
data
deriv
anim
human
analysi
conform
epitop
recogn
infect
immun
guinea
pig
subject
futur
studi
previou
immunolog
studi
use
overlap
peptid
character
linear
epitop
influenza
pathogen
mix
result
although
pepscan
identifi
epitop
hiv
measl
sar
borna
viru
prior
studi
type
analysi
fail
detect
linear
epitop
within
ha
glycoprotein
howev
continu
improv
peptid
synthesi
suggest
approach
revisit
expand
encompass
entir
ha
protein
interestingli
data
studi
identifi
two
immunodomin
epitop
repres
peptid
ntermin
amino
acid
recogn
preimmun
immun
sera
interpret
reactiv
preimmun
sera
remain
open
result
suggest
recognit
viral
epitop
present
innat
repertoir
possibl
preinfect
recognit
play
role
skew
immun
system
toward
oligoclon
rather
polyclon
respons
induct
immun
respons
limit
small
set
epitop
may
accentu
recognit
immunodomin
epitop
often
present
region
high
genet
variabl
class
ii
pathogen
abil
take
advantag
propens
host
immun
system
mount
strainspecif
immun
respons
larg
limit
variabl
immunodomin
epitop
may
pathogenesi
trait
influenza
virus
evolv
increas
fit
landscap
made
rug
host
immun
serum
high
dose
immun
group
group
show
increas
reactiv
peptid
figur
repres
highli
variabl
immunogen
loop
epitop
unexpectedli
reactiv
addit
peptid
deriv
region
outsid
previous
defin
epitop
near
transmembran
domain
observ
multipl
immun
two
infecti
innocula
amino
acid
sequenc
core
peptid
highli
conserv
among
influenza
strain
observ
linear
epitop
preclud
reactiv
sera
domin
conform
epitop
detect
method
howev
recent
studi
crossreact
epitop
avian
influenza
serotyp
meuller
et
al
identifi
sever
linear
epitop
ha
similar
use
overlap
peptid
elisa
align
set
peptid
use
studi
determin
analog
peptid
result
compar
easili
data
shown
interestingli
analogu
mani
peptid
recogn
present
studi
also
recogn
sera
avian
ha
glycoprotein
avian
sera
recogn
analogu
peptid
recogn
preimmun
guinea
pig
sera
addit
avian
sera
also
recogn
analogu
peptid
contribut
reactiv
peptid
toward
antivir
activ
requir
investig
futur
studi
plan
character
pepscan
reactiv
sera
human
infect
immun
influenza
overal
current
studi
provid
valuabl
immunogen
data
character
immun
respons
rel
new
anim
model
human
influenza
infect
vaccin
present
immunolog
comparison
guinea
pig
infect
intranas
viru
immun
recombin
ha
subunit
homolog
strain
sera
guinea
pig
treatment
group
collect
six
month
period
compar
serolog
chang
induc
treatment
total
antibodi
measur
elisa
antivir
respons
hi
assay
recogn
linear
epitop
identifi
pepscan
elisa
result
studi
reenforc
extend
previou
report
character
infect
guinea
pig
follow
inocul
unadapt
human
influenza
strain
infect
guinea
pig
mount
vigor
immun
respons
antivir
activ
measur
hi
assay
guinea
pig
immun
purifi
ha
protein
develop
similar
antivir
activ
pepscan
data
determin
sera
anim
recogn
linear
epitop
defin
epitop
anoth
epitop
near
fusion
ha
cleavag
site
studi
requir
determin
whether
innat
reactiv
also
found
sera
human
import
assess
whether
antibodi
offer
protect
immun
dysregulatori
natur
pepscan
data
also
demonstr
reactiv
sera
infect
immun
anim
linear
determin
locat
within
outsid
previous
defin
major
epitop
chang
pepscan
profil
cours
immun
infect
regimen
appear
reflect
matur
humor
immun
respons
linear
epitop
alter
immunogen
domin
yet
variabl
epitop
may
possibl
refocu
immun
respons
toward
highli
conserv
epitop
deriv
broadli
crossprotect
influenza
vaccin
subunit
vaccin
along
welldefin
anim
model
influenza
research
potenti
rapidli
accur
guid
develop
futur
vaccin
season
pandem
influenza
outbreak
influenza
obtain
center
diseas
control
prevent
viru
origin
deriv
reassort
contain
gene
encod
ha
neuraminidas
wyom
gene
apuerto
viru
viru
propag
monolay
cultur
madindarbi
canin
kidney
mdck
cell
atcc
use
dulbecco
modifi
eagl
medium
lonza
supplement
fetal
bovin
serum
lonza
plaqu
assay
viru
sampl
serial
dilut
ml
phosphat
buffer
salin
pb
place
plate
confluent
mdck
cell
h
incub
innocula
replac
mixtur
molten
agar
complet
growth
media
upon
solidif
agar
plate
invert
incub
humidifi
incub
plaqu
typic
visibl
enumer
isol
day
inocul
prior
introduct
anim
mdck
propag
viru
stock
titer
use
plaqu
assay
adjust
plaqueform
unitsml
pfuml
steril
salin
recombin
influenza
hemagglutinin
ha
produc
stabli
transform
drosophila
cell
briefli
gene
subclon
parent
plasmid
vector
kind
gift
dr
kanta
subbarao
niaid
nih
invitrogen
inc
matur
ectodomain
amino
acid
infram
bip
insect
cell
promot
sequenc
encod
hexahistadin
tract
insert
immedi
upstream
stop
codon
drosophila
cell
cotransfect
ha
express
plasmid
pcoblast
invitrogen
inc
stabl
transform
select
blastocidin
microgramsml
thermo
fisher
scientif
express
recombin
ha
protein
induc
four
day
addit
mm
cupric
sulfat
cultur
media
express
condit
supernat
contain
secret
ha
protein
clarifi
g
min
ha
protein
purifi
multistep
process
includ
chromatographi
coppercharg
fast
flow
sepharos
ge
bio
use
elut
mm
imidazol
lentil
lectin
agaros
vector
lab
use
elut
alphamethlydmannosid
final
anion
exchang
resin
whatman
ph
elut
mm
nacl
elut
sampl
concentr
buffer
exchang
chromatographi
step
use
filtrat
spincartridg
molecular
weight
cutoff
membran
amicon
ultra
centrifug
filter
devic
millipor
protein
yield
puriti
determin
use
pierc
coomassi
protein
assay
reagent
bovin
serum
albumin
standard
western
blot
comparison
commerci
prepar
standard
fulllength
awyom
ha
glycoprotein
kind
gift
dr
joseph
rining
protein
scienc
corpor
mock
prepar
ha
ectodomain
protein
produc
use
express
purif
method
stabli
transform
cell
contain
empti
pmtbip
vector
lack
ha
gene
use
neg
control
immun
experi
six
eight
week
age
guinea
pig
obtain
harlanspraquedowley
inc
anim
studi
perform
biocon
inc
rockvil
md
follow
appropri
aaalacapprov
guidelin
human
treatment
anim
research
guinea
pig
divid
four
group
tabl
test
bleed
collect
prior
studi
group
n
guinea
pig
immun
subcutan
mock
prepar
neg
control
protein
serv
neg
control
group
n
lightli
anesthet
intranas
inocul
ml
influenza
viru
pfuml
anim
reinfect
five
week
first
inocul
dose
viru
guinea
pig
group
n
subcutan
immun
recombin
ha
protein
complet
freund
adjuv
thermo
fisher
scientif
boost
week
ha
protein
incomplet
freund
adjuv
thermo
fisher
scientif
character
boost
effect
ha
antigen
initi
experiment
design
also
includ
comparison
increas
antigen
load
studi
anim
respond
increas
concentr
antigen
attempt
scale
amount
recombin
ha
protein
would
present
natur
infect
anim
group
immun
three
time
microgram
given
final
boost
microgram
week
postprim
group
anim
immun
three
time
microgram
recombin
ha
final
boost
microgram
interv
group
control
guinea
pig
immun
mock
protein
prepar
deriv
insect
cell
system
use
propag
ha
recombin
antigen
guinea
pig
serum
sampl
assess
induct
specif
ha
antibodi
respons
use
standard
elisa
method
briefli
nunc
maxisorb
flatbottom
plate
coat
overnight
mlwell
contain
microgram
fulllength
awyom
ha
protein
protein
scienc
corpor
plate
block
nonfat
dri
milk
pb
h
serum
sampl
serial
dilut
milk
solut
microlit
aliquot
test
bind
antigen
triplic
h
incub
plate
wash
pb
contain
pbst
probe
peroxidaseconjug
goat
antiguinea
pig
total
igg
antibodi
kirkegaard
perri
laboratori
inc
gaithersburg
md
kpl
h
addit
wash
bound
conjug
quantit
addit
tetramethylbenzidin
tmb
substrat
kpl
sec
follow
equal
volum
sulphur
acid
plate
read
nm
mean
valu
triplic
well
calcul
plate
background
determin
antigenco
well
detect
secondari
antibodi
elisa
extinct
titer
calcul
maximum
serum
dilut
result
signal
exceed
valu
three
time
plate
background
approxim
od
unit
mean
valu
error
bar
equal
one
standard
deviat
triplic
graph
function
time
cours
studi
specif
immun
respons
ha
protein
assess
western
blot
analysi
sampl
contain
ng
fulllength
recombin
awyom
ha
protein
protein
scienc
inc
electrophores
trisglycin
gel
invitrogen
transfer
nitrocellulos
membran
membran
cut
replic
lane
singl
strip
block
solut
nonfat
dri
milk
pb
probe
sera
immun
infect
guinea
pig
wash
pbst
strip
detect
peroxidaseconjug
goat
antiguinea
pig
antibodi
wash
develop
west
pico
chemiluminesc
substrat
pierc
blot
expos
xray
film
imag
strip
assembl
comparison
standard
hi
assay
perform
blind
fashion
assess
neutral
antibodi
level
prior
assay
serum
sampl
treat
receptor
destroy
enzym
rde
denka
seiken
co
ltd
tokyo
japan
overnight
follow
heat
inactiv
hour
twofold
dilut
serum
sampl
mix
viru
concentr
hemagglutin
unit
per
well
incub
min
room
temperatur
ml
suspens
chicken
red
blood
cell
ad
hemagglutin
assess
h
describ
map
linear
antibodi
respons
set
overlap
peptid
figur
repres
amino
acid
wyom
ha
glycoprotein
synthes
mimotop
inc
melbourn
australia
peptid
repres
amino
terminu
precursor
protein
includ
signal
leader
sequenc
synthes
ctermin
linker
four
residu
follow
biotin
label
peptid
synthes
ntermin
linker
ntermin
biotin
peptid
contain
residu
overlap
sequenc
neighbour
peptid
residu
peptid
synthes
biotin
conjug
facilit
bind
streptavidinco
microtit
plate
figur
show
overlap
design
peptid
nterminu
number
assign
individu
peptid
assess
immun
recognit
linear
epitop
peptid
bound
plate
test
reactiv
serum
sampl
briefli
ml
microgramml
solut
streptavidin
promega
introduc
well
nunc
maxisorp
plate
allow
evapor
overnight
plate
wash
ten
time
pbst
block
h
pbst
evacu
peptid
ml
solut
adjust
microgramml
place
well
allow
bind
overnight
rins
pbst
plate
block
overnight
nonfat
dri
milk
rins
pbst
guinea
pig
serum
sampl
dilut
milk
incub
well
h
plate
wash
pbst
probe
microgramsml
solut
peroxidaseconjug
goat
antiguinea
pig
igg
h
wash
develop
tmb
solut
bound
antibodi
detect
standard
plate
reader
use
method
describ
elisa
detect
